The NIAID-Supported Pathogen Functional Genomics Resource Center at the J. Craig Venter Institute Offers New Affymetrix Array for Faster Identification of E. Coli and Shigella

Affymetrix, Inc. (Nasdaq:AFFX) and the National Institute of Allergy and Infectious Diseases (NIAID)-supported Pathogen Functional Genomics Resource Center (PFGRC) at the J. Craig Venter Institute (JCVI) today announced the launch of the Affymetrix FDA-ECSG custom microarray for identifying and discriminating between different strains of E. coli and Shigella. This custom array was developed for the FDA and is now available to researchers worldwide. Affymetrix and JCVI have collaborated to make this array available from the PFGRC at no cost to researchers through the NIAID-sponsored PFGRC microarray application process.

Source: Affymetrix